Bruno Mnard - Sanofi SA Chief officer
| SAN Stock | EUR 90.80 0.80 0.89% |
Insider
Bruno Mnard is Chief officer of Sanofi SA
| Phone | 33 1 53 77 40 00 |
| Web | https://www.sanofi.com |
Sanofi SA Management Efficiency
The company has return on total asset (ROA) of 0.0559 % which means that it generated a profit of $0.0559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1177 %, meaning that it generated $0.1177 on every $100 dollars invested by stockholders. Sanofi SA's management efficiency ratios could be used to measure how well Sanofi SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Gregoire Thibault | Vinci SA | 43 | |
| Franoise Lauvin | LOreal SA | N/A | |
| Alban Nesle | AXA SA | 53 | |
| Vronique PenchienatiBosetta | Danone SA | 56 | |
| Gregoire Montchalin | AXA SA | N/A | |
| Francois Jackow | Air Liquide SA | 54 | |
| Herve Adam | Vinci SA | N/A | |
| Gilles Godard | Vinci SA | N/A | |
| Christiane Muller | Air Liquide SA | N/A | |
| Xavier Huillard | Vinci SA | 69 | |
| Andrew WallaceBarnett | AXA SA | N/A | |
| Franois Abrial | Air Liquide SA | 61 | |
| Antoine SaintAffrique | Danone SA | 59 | |
| Michael Graff | Air Liquide SA | 68 | |
| Vismay Sharma | LOreal SA | 51 | |
| Michel DavidWeill | Danone SA | 91 | |
| Frdric Roz | LOreal SA | 62 | |
| Pierre Duprat | Vinci SA | 60 | |
| Fabienne Lecorvaisier | Air Liquide SA | 61 | |
| Henri Bruxelles | Danone SA | 58 | |
| Nicolas Hieronimus | LOreal SA | 59 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0559 |
Sanofi SA Leadership Team
Elected by the shareholders, the Sanofi SA's board of directors comprises two types of representatives: Sanofi SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sanofi. The board's role is to monitor Sanofi SA's management team and ensure that shareholders' interests are well served. Sanofi SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sanofi SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JeanBaptiste Chatillon, Ex CFO | ||
| Roy Papatheodorou, Gen VP | ||
| Josephine Fubara, Chief Care | ||
| Paul Hudson, CEO Director | ||
| Bruno Mnard, Chief officer | ||
| Pierre Chancel, Sr Marketing | ||
| Laurent Gilhodes, Principal Accounting | ||
| Dante Beccaria, Global VP | ||
| Eva SchaeferJansen, Head Relations | ||
| Josep Catlla, Head Communications |
Sanofi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sanofi SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0559 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 128.44 B | |||
| Shares Outstanding | 1.25 B | |||
| Shares Owned By Insiders | 11.23 % | |||
| Shares Owned By Institutions | 47.20 % | |||
| Price To Earning | 8.63 X | |||
| Price To Book | 1.61 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Sanofi Stock analysis
When running Sanofi SA's price analysis, check to measure Sanofi SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi SA is operating at the current time. Most of Sanofi SA's value examination focuses on studying past and present price action to predict the probability of Sanofi SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi SA's price. Additionally, you may evaluate how the addition of Sanofi SA to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |